Validation of methylation-sensitive high-resolution melting (MS-HRM) for the detection of stool DNA methylation in colorectal neoplasms

Clinica Chimica Acta

Volumn 431, Issue , 2014, Pages 154-163

  Xiao, Zhujun ^a,b   Li, Bingsheng ^a,c   Wang, Guozhen ^a,b   Zhu, Weisi ^a,b   Wang, Zhongqiu ^a,b   Lin, Jinfeng ^a,b   Xu, Angao ^a,d   Wang, Xinying ^a,b  

^a SOUTHERN MEDICAL UNIVERSITY   (China)

^b Guangdong Provincial Key Laboratory of Gastroenterology   (China)

^c Huizhou First Hospital   (China)

^d Huizhou Medicine Institute   (China)

Author keywords

Advanced adenoma; Cancer screening; Colorectal cancer; DNA methylation; Methylation sensitive high resolution melting (MS HRM); SFRP2 VIM

Indexed keywords

SECRETED FRIZZLED RELATED PROTEIN 2; VIMENTIN; BISULFITE; MEMBRANE PROTEIN; SFRP2 PROTEIN, HUMAN; SULFITE; TUMOR MARKER;

ADENOMA; ADULT; ADVANCED ADENOMA; ADVANCED CANCER; AGED; ARTICLE; BISULFITE SEQUENCING POLYMERASE CHAIN REACTION; CANCER SCREENING; CASE CONTROL STUDY; COLORECTAL CANCER; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; DNA DETERMINATION; DNA METHYLATION; FALSE NEGATIVE RESULT; FALSE POSITIVE RESULT; FEASIBILITY STUDY; FECES ANALYSIS; FEMALE; HIGH RESOLUTION MELTING ANALYSIS; HUMAN; HUMAN TISSUE; IMMUNOCHEMISTRY; INTERMETHOD COMPARISON; LIMIT OF DETECTION; MAJOR CLINICAL STUDY; MALE; METHYLATION SENSITIVE HIGH RESOLUTION MELTING; METHYLATION SPECIFIC POLYMERASE CHAIN REACTION; NUCLEOTIDE SEQUENCE; OCCULT BLOOD; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY; SFRP2 GENE; VALIDATION STUDY; CHEMISTRY; COLORECTAL NEOPLASMS; FECES; GENETICS; METHYLATION; MIDDLE AGED; PROCEDURES; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; COLORECTAL NEOPLASMS; DNA METHYLATION; FECES; FEMALE; HUMANS; MALE; MEMBRANE PROTEINS; METHYLATION; MIDDLE AGED; OCCULT BLOOD; POLYMERASE CHAIN REACTION; REPRODUCIBILITY OF RESULTS; SULFITES; TUMOR MARKERS, BIOLOGICAL; VIMENTIN;

EID: 84896717678     PISSN: 00098981     EISSN: 18733492     Source Type: Journal    
DOI: 10.1016/j.cca.2014.01.044     Document Type: Article

References (55)

1. Jemal A., Bray F., Center M.M., Ferlay J., Ward E., Forman D. Global cancer statistics. CA Cancer J Clin 2011, 61:69-90.
2. Chen W., Zheng R., Zhang S., et al. Report of incidence and mortality in China cancer registries, 2009. Chin J Cancer Res 2013, 25:10-21.
3. Li B.S., Wang X.Y., Xu A.G., et al. High-resolution melting assay (HRMA) is a simple and sensitive stool-based DNA test for the detection of mutations in colorectal neoplasms. Clin Colorectal Cancer 2012, 11:280-290.
4. Tang D., Liu J., Wang D.R., Yu H.F., Li Y.K., Zhang J.Q. Diagnostic and prognostic value of the methylation status of secreted frizzled-related protein 2 in colorectal cancer. Clin Invest Med 2011, 34:E88-E95.
5. Matsubara N. Epigenetic regulation and colorectal cancer. Dis Colon Rectum 2012, 55:96-104.
6. Draht M.X., Riedl R.R., Niessen H., et al. Promoter CpG island methylation markers in colorectal cancer: the road ahead. Epigenomics 2012, 4:179-194.
7. Kim H.C., Roh S.A., Ga I.H., Kim J.S., Yu C.S., Kim J.C. CpG island methylation as an early event during adenoma progression in carcinogenesis of sporadic colorectal cancer. J Gastroenterol Hepatol 2005, 20:1920-1926.
8. Peng L., Hu J., Li S., et al. Aberrant methylation of the PTCH1 gene promoter region in aberrant crypt foci. Int J Cancer 2013, 132:E18-E25.
9. Lenhard K., Bommer G.T., Asutay S., et al. Analysis of promoter methylation in stool: a novel method for the detection of colorectal cancer. Clin Gastroenterol Hepatol 2005, 3:142-149.
10. Bosch L.J., Mongera S., Sive D.J., et al. Analytical sensitivity and stability of DNA methylation testing in stool samples for colorectal cancer detection. Cell Oncol (Dordr) 2012, 35:309-315.
11. van Dam L., Kuipers E.J., van Leerdam M.E. Performance improvements of stool-based screening tests. Best Pract Res Clin Gastroenterol 2010, 24:479-492.
12. Ahlquist D.A., Sargent D.J., Loprinzi C.L., et al. Stool DNA and occult blood testing for screen detection of colorectal neoplasia. Ann Intern Med 2008, 149:441-450. [W81].
13. Bosch L.J., Carvalho B., Fijneman R.J., et al. Molecular tests for colorectal cancer screening. Clin Colorectal Cancer 2011, 10:8-23.
14. Ned R.M., Melillo S., Marrone M. Fecal DNA testing for colorectal cancer screening: the ColoSure test. PLoS Curr 2011, 3:RRN1220.
15. Wang D.R., Tang D. Hypermethylated SFRP2 gene in fecal DNA is a high potential biomarker for colorectal cancer noninvasive screening. World J Gastroenterol 2008, 14:524-531.
16. Suzuki H., Watkins D.N., Jair K.W., et al. Epigenetic inactivation of SFRP genes allows constitutive WNT signaling in colorectal cancer. Nat Genet 2004, 36:417-422.
17. Muller H.M., Oberwalder M., Fiegl H., et al. Methylation changes in faecal DNA: a marker for colorectal cancer screening?. Lancet 2004, 363:1283-1285.
18. Suzuki H., Gabrielson E., Chen W., et al. A genomic screen for genes upregulated by demethylation and histone deacetylase inhibition in human colorectal cancer. Nat Genet 2002, 31:141-149.
19. Suzuki H., Toyota M., Nojima M., Mori M., Imai K. SFRP, a family of new colorectal tumor suppressor candidate genes. Nihon Rinsho 2005, 63:707-719.
20. Huang Z., Li L., Wang J. Hypermethylation of SFRP2 as a potential marker for stool-based detection of colorectal cancer and precancerous lesions. Dig Dis Sci 2007, 52:2287-2291.
21. Oberwalder M., Zitt M., Wontner C., et al. SFRP2 methylation in fecal DNA-a marker for colorectal polyps. Int J Colorectal Dis 2008, 23:15-19.
22. Miller S., Steele S. Novel molecular screening approaches in colorectal cancer. J Surg Oncol 2012, 105:459-467.
23. Chen W.D., Han Z.J., Skoletsky J., et al. Detection in fecal DNA of colon cancer-specific methylation of the nonexpressed vimentin gene. J Natl Cancer Inst 2005, 97:1124-1132.
24. Shirahata A., Sakata M., Sakuraba K., et al. Vimentin methylation as a marker for advanced colorectal carcinoma. Anticancer Res 2009, 29:279-281.
25. Itzkowitz S., Brand R., Jandorf L., et al. A simplified, noninvasive stool DNA test for colorectal cancer detection. Am J Gastroenterol 2008, 103:2862-2870.
26. Baek Y.H., Chang E., Kim Y.J., Kim B.K., Sohn J.H., Park D.I. Stool methylation-specific polymerase chain reaction assay for the detection of colorectal neoplasia in Korean patients. Dis Colon Rectum 2009, 52:1452-1459. [discussion 1459-1463].
27. Mikeska T., Bock C., Do H., Dobrovic A. DNA methylation biomarkers in cancer: progress towards clinical implementation. Expert Rev Mol Diagn 2012, 12:473-487.
28. Ahlquist D.A., Zou H., Domanico M., et al. Next-generation stool DNA test accurately detects colorectal cancer and large adenomas. Gastroenterology 2012, 142:248-256. [quiz e25-26].
29. Cummings L.C., Cooper G.S. Colorectal cancer screening: update for 2011. Semin Oncol 2011, 38:483-489.
30. Chung D.C. Stool DNA testing and colon cancer prevention: another step forward. Ann Intern Med 2008, 149:509-510.
31. Coffee B. Methylation-specific PCR. Curr Protoc Hum Genet 2009, 61:10.6.1-10.6.14.
32. Kristensen L.S., Hansen L.L. PCR-based methods for detecting single-locus DNA methylation biomarkers in cancer diagnostics, prognostics, and response to treatment. Clin Chem 2009, 55:1471-1483.
33. Licchesi J.D., Herman J.G. Methylation-specific PCR. Methods Mol Biol 2009, 507:305-323.
34. Ammerpohl O., Martin-Subero J.I., Richter J., Vater I., Siebert R. Hunting for the 5th base: techniques for analyzing DNA methylation. Biochim Biophys Acta 2009, 1790:847-862.
35. Patterson K., Molloy L., Qu W., Clark S. DNA methylation: bisulphite modification and analysis. J Vis Exp 2011, 56:3170.
36. Reed K., Poulin M.L., Yan L., Parissenti A.M. Comparison of bisulfite sequencing PCR with pyrosequencing for measuring differences in DNA methylation. Anal Biochem 2010, 397:96-106.
37. Vossen R.H., Aten E., Roos A., den Dunnen J.T. High-resolution melting analysis (HRMA): more than just sequence variant screening. Hum Mutat 2009, 30:860-866.
38. Montgomery J.L., Sanford L.N., Wittwer C.T. High-resolution DNA melting analysis in clinical research and diagnostics. Expert Rev Mol Diagn 2010, 10:219-240.
39. Wittwer C.T. High-resolution DNA melting analysis: advancements and limitations. Hum Mutat 2009, 30:857-859.
40. Balic M., Pichler M., Strutz J., et al. High quality assessment of DNA methylation in archival tissues from colorectal cancer patients using quantitative high-resolution melting analysis. J Mol Diagn 2009, 11:102-108.
41. Kristensen L.S., Wojdacz T.K., Thestrup B.B., Wiuf C., Hager H., Hansen L.L. Quality assessment of DNA derived from up to 30years old formalin fixed paraffin embedded (FFPE) tissue for PCR-based methylation analysis using SMART-MSP and MS-HRM. BMC Cancer 2009, 9:453.
42. Liu W., Guan M., Su B., et al. Rapid determination of AKAP12 promoter methylation levels in peripheral blood using methylation-sensitive high resolution melting (MS-HRM) analysis: application in colorectal cancer. Clin Chim Acta 2010, 411:940-946.
43. Osborn N.K., Ahlquist D.A. Stool screening for colorectal cancer: molecular approaches. Gastroenterology 2005, 128:192-206.
44. Berger B.M., Ahlquist D.A. Stool DNA screening for colorectal neoplasia: biological and technical basis for high detection rates. Pathology 2012, 44:80-88.
45. Wojdacz T.K., Dobrovic A. Methylation-sensitive high resolution melting (MS-HRM): a new approach for sensitive and high-throughput assessment of methylation. Nucleic Acids Res 2007, 35:e41.
46. Li Z., Zhang W., Shao Y., et al. High-resolution melting analysis of ADAMTS18 methylation levels in gastric, colorectal and pancreatic cancers. Med Oncol 2010, 27:998-1004.
47. Zhang C., Shao Y., Zhang W., et al. High-resolution melting analysis of ADAMTS9 methylation levels in gastric, colorectal, and pancreatic cancers. Cancer Genet Cytogenet 2010, 196:38-44.
48. Candiloro I.L., Mikeska T., Dobrovic A. Closed-tube PCR methods for locus-specific DNA methylation analysis. Methods Mol Biol 2011, 791:55-71.
49. Li M., Chen W.D., Papadopoulos N., et al. Sensitive digital quantification of DNA methylation in clinical samples. Nat Biotechnol 2009, 27:858-863.
50. Nagasaka T., Tanaka N., Cullings H.M., et al. Analysis of fecal DNA methylation to detect gastrointestinal neoplasia. J Natl Cancer Inst 2009, 101:1244-1258.
51. Leung W.K., To K.F., Man E.P., et al. Detection of hypermethylated DNA or cyclooxygenase-2 messenger RNA in fecal samples of patients with colorectal cancer or polyps. Am J Gastroenterol 2007, 102:1070-1076.
52. Park D.I., Ryu S., Kim Y.H., et al. Comparison of guaiac-based and quantitative immunochemical fecal occult blood testing in a population at average risk undergoing colorectal cancer screening. Am J Gastroenterol 2010, 105:2017-2025.
53. Malentacchi F., Forni G., Vinci S., Orlando C. Quantitative evaluation of DNA methylation by optimization of a differential-high resolution melt analysis protocol. Nucleic Acids Res 2009, 37:e86.
54. Migheli F., Stoccoro A., Coppede F., et al. Comparison study of MS-HRM and pyrosequencing techniques for quantification of APC and CDKN2A gene methylation. PLoS One 2013, 8:e52501.
55. van Dam L., Kuipers E.J., Steyerberg E.W., van Leerdam M.E., de Beaufort I.D. The price of autonomy: should we offer individuals a choice of colorectal cancer screening strategies?. Lancet Oncol 2013, 14:e38-e46.